Agilent Technologies Inc
Company Profile
Business description
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Contact
5301 Stevens Creek Boulevard
Santa ClaraCA95051
USAT: +1 800 227-9770
E: parmeet_ahuja@agilent.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 October 2025
Employees
17,400
Stocks News & Analysis
stocks
Microsoft earnings: Strength in cloud, guidance mixed
stocks
Chart of the week: Small caps lagging
stocks
An impending merger just raised our fair value for this ASX retail giant
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,344.80 | 77.30 | -0.92% |
| CAC 40 | 7,350.37 | 77.99 | -1.05% |
| DAX 40 | 19,077.54 | 179.80 | -0.93% |
| Dow JONES (US) | 41,763.46 | 378.08 | -0.90% |
| FTSE 100 | 8,110.10 | 49.53 | -0.61% |
| HKSE | 20,317.33 | 63.31 | -0.31% |
| NASDAQ | 18,095.15 | 512.78 | -2.76% |
| Nikkei 225 | 39,081.25 | 196.14 | -0.50% |
| NZX 50 Index | 12,579.18 | 59.72 | -0.47% |
| S&P 500 | 5,705.45 | 108.22 | -1.86% |
| S&P/ASX 200 | 8,083.80 | 76.20 | -0.93% |
| SSE Composite Index | 3,279.82 | 13.59 | 0.42% |